Breaking News, Promotions & Moves

PurMinds NeuroPharma Names New Chief Business Officer

Vanessa Williamson joins the company during a pivotal stage of growth.

Author Image

By: Charlie Sternberg

Associate Editor

PurMinds NeuroPharma, a clinical-stage neuroscience company focused on advancing a pipeline of small molecules, psychedelic compounds, and other modalities for the treatment of neurological and neurodegenerative disorders, has named Vanessa Williamson as Chief Business Officer, effective May 20, 2024.   “We are thrilled to welcome Vanessa to the PurMinds leadership team during this pivotal stage of our growth,” said Janet Qi, CPA. MBA. Co-Founder & CEO of PurMinds NeuroPharma. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters